Contacts | Sitemap | In Swedish 
FRONTPAGE
About Priveq
Our Professionals
Portfolio Companies
Investment Criteria
Media
Contact us
05-11-2009
Priveq Investment helps create new specialist pharmaceuticals company
Priveq has entered an agreement to divest its holding in pharmaceuticals company Swedish Orphan International to Biovitrum today, creating Swedish Orphan Biovitrum AB.
   Printer-friendly version
Document
PRIVEQ INVESTMENT | Box 5295, SE-102 46 Stockholm, Sweden | Visitors: Riddargatan 17 | Tel: +46 (0)8 459 67 60 | Fax: +46 (0)8 20 35 66 | info@priveq.se